ES2650733T3 - Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso - Google Patents
Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso Download PDFInfo
- Publication number
- ES2650733T3 ES2650733T3 ES12848401.1T ES12848401T ES2650733T3 ES 2650733 T3 ES2650733 T3 ES 2650733T3 ES 12848401 T ES12848401 T ES 12848401T ES 2650733 T3 ES2650733 T3 ES 2650733T3
- Authority
- ES
- Spain
- Prior art keywords
- domain
- terminal
- antibody specific
- profilagrin
- terminal domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004899 c-terminal region Anatomy 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000035772 mutation Effects 0.000 abstract 2
- 239000002390 adhesive tape Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011245483A JP5771123B2 (ja) | 2011-11-09 | 2011-11-09 | プロフィラグリンｃ末端ドメイン特異的抗体及びその用途 |
| JP2011245483 | 2011-11-09 | ||
| PCT/JP2012/079015 WO2013069741A1 (ja) | 2011-11-09 | 2012-11-08 | プロフィラグリンc末端ドメイン特異的抗体及びその用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2650733T3 true ES2650733T3 (es) | 2018-01-22 |
Family
ID=48290111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12848401.1T Active ES2650733T3 (es) | 2011-11-09 | 2012-11-08 | Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20140287431A1 (enExample) |
| EP (1) | EP2778174B1 (enExample) |
| JP (1) | JP5771123B2 (enExample) |
| KR (1) | KR102025446B1 (enExample) |
| CN (1) | CN104039827B (enExample) |
| ES (1) | ES2650733T3 (enExample) |
| WO (1) | WO2013069741A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| WO2020076770A1 (en) * | 2018-10-08 | 2020-04-16 | Yale University | Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4162259B2 (ja) * | 1991-04-26 | 2008-10-08 | ビオメリュー・ソシエテ・アノニム | リウマチ性関節炎抗体により認識される抗原、抗原製剤及びその適用方法 |
| CA2570887C (en) * | 2004-06-18 | 2014-09-16 | Genentech, Inc. | Tumor treatment |
| GB0525492D0 (en) * | 2005-12-15 | 2006-01-25 | Univ Dundee | Filaggrin |
| JP2007217325A (ja) * | 2006-02-16 | 2007-08-30 | Kose Corp | プロフィラグリン及び／又はフィラグリン産生促進剤 |
| WO2011068166A1 (ja) * | 2009-12-03 | 2011-06-09 | 株式会社資生堂 | ブレオマオシン水解酵素の活性を指標としたアトピー性皮膚炎による乾燥肌改善剤のスクリーニング方法 |
-
2011
- 2011-11-09 JP JP2011245483A patent/JP5771123B2/ja active Active
-
2012
- 2012-11-08 EP EP12848401.1A patent/EP2778174B1/en active Active
- 2012-11-08 KR KR1020147011999A patent/KR102025446B1/ko not_active Expired - Fee Related
- 2012-11-08 US US14/356,985 patent/US20140287431A1/en not_active Abandoned
- 2012-11-08 CN CN201280066201.0A patent/CN104039827B/zh active Active
- 2012-11-08 ES ES12848401.1T patent/ES2650733T3/es active Active
- 2012-11-08 WO PCT/JP2012/079015 patent/WO2013069741A1/ja not_active Ceased
-
2018
- 2018-09-20 US US16/136,929 patent/US20190079080A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104039827A (zh) | 2014-09-10 |
| EP2778174B1 (en) | 2017-11-01 |
| WO2013069741A1 (ja) | 2013-05-16 |
| EP2778174A4 (en) | 2015-06-24 |
| US20190079080A1 (en) | 2019-03-14 |
| HK1201856A1 (en) | 2015-09-11 |
| CN104039827B (zh) | 2016-12-14 |
| JP5771123B2 (ja) | 2015-08-26 |
| KR20140089366A (ko) | 2014-07-14 |
| KR102025446B1 (ko) | 2019-09-25 |
| JP2013100249A (ja) | 2013-05-23 |
| EP2778174A1 (en) | 2014-09-17 |
| US20140287431A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
| ES2486675T3 (es) | Análogo de péptido de oxintomodulina | |
| CL2019002264A1 (es) | Anticuerpos anti-lag3 radiomarcados para la obtención de imágenes mediante inmuno-pet. | |
| ES2570731T3 (es) | Método de detección de cáncer | |
| NZ595707A (en) | Cancer antigen helper peptide | |
| EA201490265A1 (ru) | Ингибиторы тирозинкиназы брутона | |
| CY1120055T1 (el) | Αντικαρκινικη πρωτεϊνη συντηξης | |
| MX389093B (es) | Composiciones y metodos para la glicosilacion de proteinas. | |
| EA201400488A1 (ru) | Полипептидные конструкции и их применение | |
| CL2017000200A1 (es) | Célula huésped mejorada para producir proteinas | |
| PE20130205A1 (es) | Proteinas de union a il-1 | |
| PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
| RU2019119609A (ru) | Пептиды, способные реактивировать мутанты р53 | |
| CY1118200T1 (el) | Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης | |
| ECSP13012673A (es) | Métodos y composiciones para inmunoterapia para enfermedad neural | |
| CL2014003112A1 (es) | Célula bacteriana gram-negativa recombinante que comprende un gen spr mutante y un gen capaz de expresar o sobreexpresar proteínas capaces de facilitar el plegamiento de proteínas; y método para producir proteínas de interés. | |
| CY1119149T1 (el) | Αντικαρκινικη πρωτεϊνη συντηξης | |
| BR112016016737A2 (pt) | Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma | |
| CL2012002900A1 (es) | Secuencias de acido nucleico procedente de un virus causante del sindrome de miocardiopatia (cms) en peces; vector; celula huesped; vacuna de adn; proteina recombinante codificada; vacuna recombinante; inmunoensayo para la deteccion de dicho virus; kit de diagnostico; y uso de las mismas. | |
| AR098126A1 (es) | Anticuerpos anti-ly6e (locus e del complejo del antígeno 6 linfocítico), inmunoconjugados y métodos para usarlos | |
| ES2650733T3 (es) | Anticuerpo específico para el dominio C-terminal de la profilagrina y su uso | |
| CL2014000891A1 (es) | Metodo de seleccion de pescado que comprende identificar en la muestra la presencia de variaciones de secuencia dentro de secuencias nucleotidicas o aminoacídicas de proteinas; anticuerpo que se une a dichas proteinas o secuencias; kit para identificar y/o determinar variantes de la calidad de la carne asociada a un gen/proteina; un arreglo de ácidos nucleicos. | |
| MX393714B (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. | |
| MX384636B (es) | Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano. | |
| ES2542227T3 (es) | Tratamiento de complicaciones vasculares de diabetes |